Skip to content

Are you a clinical specialist involved in the diagnosis and management of patients with suspected dementia?

Photo: Designed by Freepik

Published 6 March 2025

PREDICTOM is inviting clinical specialists (aka secondary and tertiary care physicians) to complete this short survey. We want to hear about your current clinical practice when managing patients who you suspect have dementia. We also ask some questions about Alzheimer’s disease and mild cognitive impairment.

Your responses will help us develop recommendations for optimising clinical practice guidelines, considering new technologies to support diagnosis and facilitators and barriers to implementation.

Take part in our survey

Latest news

📱BrainCheck and the Future of Brain Health: Making It Simple

News

📱BrainCheck and the Future of Brain Health: Making It Simple

What if checking your brain health was as easy as a quick test on your phone or tablet? For millions worried about memory slips, that could be life-changing. Thanks to BrainCheck, this isn’t a dream—it’s happening now.

Read more
🏧Banking on Brain Health: How a Simple App Could Support Early Detection of Cognitive Decline

News

🏧Banking on Brain Health: How a Simple App Could Support Early Detection of Cognitive Decline

Could forgetting a PIN be more than a simple slip? Scientists behind the Banking App believe that subtle changes in how we handle financial tasks may signal early cognitive decline, including Alzheimer’s disease. By simulating ATM interactions, the app captures detailed performance metrics—such as speed, accuracy, and error patterns—that researchers use to study functional changes before traditional symptoms appear.

Read more
👁️‍🗨️Eyes on the Future: How Eye-Tracking Could Transform Early Dementia Detection

News

👁️‍🗨️Eyes on the Future: How Eye-Tracking Could Transform Early Dementia Detection

Eye-tracking technology is emerging as a promising tool for early detection of cognitive decline. By analyzing involuntary eye movements, researchers can identify subtle cognitive and attentional changes that may accompany the earliest stages of mild cognitive impairment and Alzheimer’s disease — sometimes before these changes are evident on traditional paper-based tests. This article explores the science, clinical applications, and innovations driving this breakthrough.

Read more